72190 Federal Register / Vol. 79, No. 234 / Friday, December 5, 2014 / Notices 

REPORTING REQUIREMENTS—Continued 

Regulatory/section requirements Number of 

respondents 

Responses 

per 

respondent 

Total annual 

responses 

Hours per 

response 

Total hour 

burden 

57.210(b)(1)(iii), Notification of Repayment .................. 334 862.5 288,075 0.38 108,028 

57.210(b)(1)(iv), Notification During Deferment ........... 334 17.0 5,678 0.63 3,549 

57.210(b)(1)(vi), Notification of Delinquent Accounts ... 334 172.5 57,615 1.25 72,019 

57.210(b)(1)(x), Credit Bureau Notification .................. 334 6 2,004 0.50 1,002 

57.210(b)(4)(i), Write-off of Uncollectible Loans .......... 5 1 5 3.00 15 

57.211(a) Disability Cancellation .................................. 3 1 3 1.00 3 

57.215(a)(2), Administrative Hearings .......................... 0 0 0 0 0 

57.215(a)(d), Administrative Hearings .......................... 0 0 0 0 0 

HPSL Subtotal ....................................................... ........................ ........................ ........................ ........................ 306,029 

NSL Program: 

57.306(a)(2), Student Financial Aid Transcript ............ ........................ ........................ ........................ ........................ ........................

57.310(b)(1)(i), Entrance Interview ............................... 282 17.5 4,935 0.42 2,048 

57.310(b)(1)(ii), Exit Interview ...................................... 348 9.0 3,132 0.42 1,300 

57.301(b)(1)(iii), Notification of Repayment .................. 348 9.0 3,132 0.27 830 

57.310(b)(1)(iv), Notification During Deferment ........... 348 1.5 522 0.29 151 

57.310(b)(1)(vi), Notification of Delinquent Accounts ... 348 42.5 14,790 0.04 592 

57.310(b)(1)(x), Credit Bureau Notification .................. 348 709.0 246,732 0.00 86 

57.310(b)(4)(i), Write-off of Uncollectible Loans .......... 23 1.0 23 3.00 69 

57.311(a), Disability Cancellation ................................. 16 1.0 16 1.00 16 

57.315(a)(1)(ii), Administrative Hearings ...................... 0 0 0 0 0 

57.316(a)(d), Administrative Hearings .......................... 0 0 0 0 0 

NSL Subtotal ......................................................... ........................ ........................ ........................ ........................ 5,092 

*Includes active and closing schools. 

Jackie Painter, 

Acting Director, Division of Policy and 

Information Coordination. 

[FR Doc. 2014–28555 Filed 12–4–14; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Outstanding Investigator Award 2. 

Date: March 24–26, 2015. 

Time: 6:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, MD 20878. 

Contact Person: Peter J. Wirth, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, 9609 

Medical Center Drive, Room 7W154, 

Rockville, MD 20850, 240–276–6434, pw2q@

nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Outstanding Investigator Award 1. 

Date: March 24–26, 2015. 

Time: 6:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, MD 20878. 

Contact Person: Michael B. Small, Ph.D., 

Chief, Program and Review Extramural Staff 

Training Office, Division of Extramural 

Activities, National Cancer Institute, 9609 

Medical Center Drive, Room 7W412, 

Rockville, MD 20850, 240–276–6438, 

smallm@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Outstanding Investigator Award 3. 

Date: March 24–26, 2015. 

Time: 6:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, MD 20878. 

Contact Person: Shamala K. Srinivas, 

Ph.D., Scientific Review Officer, Office of 

Referral, Review, and Program Coordination, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 9609 Medical Center 

Drive, 7W530, Rockville, MD 20850, 240– 

276–6442, ss537t@mail.nih.gov. 

Information is also available on the 

Institute’s/Center’s home page: http://

deainfo.nci.nih.gov/advisory/sep/sep.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: December 1, 2014. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–28530 Filed 12–4–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 


wreier-aviles on DSK5TPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 234 / Friday, December 5, 2014 / Notices 72191 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Board 

of Scientific Counselors, National 

Human Genome Research Institute. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Human Genome Research 

Institute, including consideration of 

personnel qualifications and 

performance, and the competence of 

individual investigators, the disclosure 

of which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Board of Scientific 

Counselors, National Human Genome 

Research Institute. 

Date: December 10–11, 2014. 

Closed: December 10, 2014, 5:00 p.m. to 

7:00 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Open: December 10, 2014, 7:00 p.m. to 9:30 

p.m. 

Agenda: To discuss matters of program 

relevance. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Open: December 11, 2014, 8:00 a.m. to 1:45 

p.m. 

Agenda: To discuss matters of program 

relevance. 

Place: National Institutes of Health, 

Natcher Conference Center, Room F1/F2 

(lower level), 45 Center Drive, Bethesda, MD 

20892. 

Closed: December 11, 2014, 1:45 p.m. to 

3:30 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes of Health, 

Natcher Conference Center, Room F1/F2 

(lower level), 45 Center Drive, Bethesda, MD 

20892. 

Open: December 11, 2014, 3:30 p.m. to 5:00 

p.m. 

Agenda: Closing Keynote. 

Place: National Institutes of Health, 

Natcher Conference Center, Room F1/F2 

(lower level), 45 Center Drive, Bethesda, MD 

20892. 

Contact Person: Monica Berger, Executive 

Secretary, Office of the Scientific Director, 

National Human Genome Research Institute, 

50 South Drive, Bldg. 50, Rm. 5222, 

Bethesda, MD 20892, 301–294–6873, 

bergerm@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the urgent 

need to meet timing limitations imposed by 

the intramural research review cycle. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.172, Human Genome 

Research, National Institutes of Health, HHS) 

Dated: December 1, 2014. 

David Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–28529 Filed 12–4–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Clinical Center; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Board 

of Scientific Counselors of the NIH 

Clinical Center. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

CLINICAL CENTER, including 

consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors of the NIH Clinical Center. 

Date: January 5–6, 2015. 

Time: 8:00 a.m. to 4:45 p.m.; 8:00 a.m. to 

11:45 a.m. 

Agenda: To review and evaluate the 

Bioethics Department. 

Place: National Institutes of Health, 

Building 10, 4–2551, 10 Center Drive, 

Bethesda, MD 20892. 

Contact Person: Mary Sparks, Nurse 

Consultant for the Deputy Director for 

Clinical Care, Office of the Deputy Director, 

Clinical Center, National Institutes of Health, 

Building 10, Room 6–3521, Bethesda, MD 

20892, (301) 496–3515. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Dated: December 1, 2014. 

Michelle Trout, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–28527 Filed 12–4–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Cognition, Diabetic Neuropathy and 

Metabolomics. 

Date: December 19, 2014. 

Time: 3:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Suzan Nadi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5217B, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1259, nadis@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 


wreier-aviles on DSK5TPTVN1PROD with NOTICES